{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:48:18Z","timestamp":1791316098754,"version":"4.3.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T00:00:00Z","timestamp":1366588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062114","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T23:07:05Z","timestamp":1366672025000},"page":"e62114","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy"],"prefix":"10.1371","volume":"8","author":[{"given":"Chalermchai","family":"Mitrpant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Porensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve D.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur H. M.","family":"Burghes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/adc.45.239.33","article-title":"The genetic component in child mortality","volume":"45","author":"DF Roberts","year":"1970","journal-title":"Archives of disease in childhood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick","volume":"10","author":"AH Burghes","year":"2009","journal-title":"Nature reviews Neuroscience"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","article-title":"Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients","volume":"213","author":"M Gennarelli","year":"1995","journal-title":"Biochemical and biophysical research communications"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"BG Burnett","year":"2009","journal-title":"Molecular and cellular biology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0598-63","article-title":"SMN oligomerization defect correlates with spinal muscular atrophy severity","volume":"19","author":"CL Lorson","year":"1998","journal-title":"Nature genetics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"S Duque","year":"2009","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"KD Foust","year":"2009","journal-title":"Nature biotechnology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","article-title":"Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect","volume":"17","author":"TO Gavrilina","year":"2008","journal-title":"Human molecular genetics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"E Dominguez","year":"2011","journal-title":"Human molecular genetics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"KD Foust","year":"2010","journal-title":"Nature biotechnology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"MA Passini","year":"2010","journal-title":"The Journal of clinical investigation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"CF Valori","year":"2010","journal-title":"Science translational medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"AK Bevan","year":"2011","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"L Cartegni","year":"2002","journal-title":"Nature genetics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"T Kashima","year":"2003","journal-title":"Nature genetics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2741\/3670","article-title":"Splicing regulation of the survival motor neuron genes and implications for treatment of spinal muscular atrophy","volume":"15","author":"TW Bebee","year":"2010","journal-title":"Frontiers in bioscience : a journal and virtual library"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Y Hua","year":"2008","journal-title":"American journal of human genetics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron","volume":"26","author":"NK Singh","year":"2006","journal-title":"Molecular and cellular biology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"MA Passini","year":"2011","journal-title":"Science translational medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"PN Porensky","year":"2012","journal-title":"Human molecular genetics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.mt.6300006","article-title":"The influence of antisense oligonucleotide length on dystrophin exon skipping","volume":"15","author":"PL Harding","year":"2007","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2199-8-57","article-title":"Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries","volume":"8","author":"AM Adams","year":"2007","journal-title":"BMC molecular biology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/mt.2009.49","article-title":"Rational design of antisense oligomers to induce dystrophin exon skipping","volume":"17","author":"C Mitrpant","year":"2009","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Zhou H, Janghra N, Mitrpant C, Dickinson R, Anthony K, <etal>et al<\/etal>. (2013) A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe SMA Transgenic Mice. Human gene therapy.","DOI":"10.1089\/hum.2012.211"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbrc.2009.11.148","article-title":"Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy","volume":"391","author":"ME Butchbach","year":"2010","journal-title":"Biochemical and biophysical research communications"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Y Hua","year":"2010","journal-title":"Genes & development"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2009.01.071","article-title":"Vascular perfusion abnormalities in infants with spinal muscular atrophy","volume":"155","author":"Q Araujo Ade","year":"2009","journal-title":"The Journal of pediatrics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Y Hua","year":"2011","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddg196","article-title":"Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle","volume":"12","author":"BL Gebski","year":"2003","journal-title":"Human molecular genetics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.WNL.0000069460.53438.38","article-title":"Single section Western blot: improving the molecular diagnosis of the muscular dystrophies","volume":"61","author":"ST Cooper","year":"2003","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"TT Le","year":"2005","journal-title":"Human molecular genetics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:29:57Z","timestamp":1588984197000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062114"}},"subtitle":[],"editor":[{"given":"Emanuele","family":"Buratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,22]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062114","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718399703.793502452","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,22]]}}}